Pharmafile Logo
Pharmafocus logo
Advanced Search
Jim Easton

Pharma faces ‘trench warfare’ with NHS

May 26, 2011
Sales and Marketing Cost cutting, NHS, prescribing

The competing interests of the NHS and the pharma industry could end in trench warfare, a leading NHS figure has …

News

BMA calls for major amendments to Health Bill

May 26, 2011
Health and Social Care Bill, NHS reforms

The BMA says the government should withdraw its plans for health reform completely and go back to the drawing board. …

News

British biotech: rebuilding momentum

May 26, 2011
Research and Development UK, biotech, biotech funding

Since biotech first emerged in the UK in the late 1980s, the dream has always been for the country to …

Feature

NICE to appraise hep C drugs Victrelis and telaprevir

May 26, 2011
Sales and Marketing Brinavess, Ilaris, NICE, Victrelis, Xarelto, Zytiga, telaprevir

NICE’s next round of drug appraisals is set to include two new hepatitis C drugs – Merck Sharpe and Dohme’s …

News

GSK’s Trobalt launched in UK

May 25, 2011
Sales and Marketing GlaxoSmithKline, Trobalt, epilepsy, retigabine

GSK has launched its new epilepsy treatment Trobalt in the UK. Trobalt (retigabine) is as adjunctive treatment of partial onset …

News

Elan signs $20m research deal with Proteostasis

May 25, 2011
Research and Development Elan, Proteostasis, neurodegenerative diseases

Elan Corporation has signed a deal with US small molecule drug specialist Proteostasis Therapeutics to develop products for conditions such …

News

Eisai extends neuroscience partnership with UCL

May 25, 2011
Research and Development Eisai, UCL, academic alliance, academic research, neurodegenerative diseases

Eisai and University College London are to extend their partnership in neuroscience research. The Japanese company’s Neuroscience Product Creation Unit …

News

Contract research news in brief

May 25, 2011
Research and Development contract research, contract research news

Mergers and acquisitions abound in our latest round-up of contract research sector news, as players try to achieve the global …

News

Mark Duckham joins Adventis Health

May 25, 2011
Medical Communications appointment, medical communications

Adventis Health has appointed Mark Duckham to the newly-created role of client services director. In his new position Mark will …

Appointment
Roche's MabThera’s (rituximab)

NICE U-turn on Roche’s MabThera

May 25, 2011
Sales and Marketing MabThera, NICE, Roche

NICE has provisionally recommended Roche’s MabThera as a maintenance therapy for blood cancer patients. The new draft guidance backs MabThera’s …

News

Pfizer will invest $21m in US injectables upgrade

May 25, 2011
Manufacturing and Production APIs, Pfizer, pharma manufacturing

Pfizer has announced another upgrade of its sterile injectables plant in Portage, Michigan, earmarking around $21 million for new air …

News

IPA Best of Health Awards shortlist revealed

May 25, 2011
Medical Communications Best of Health, IPA

The short list of agencies selected for this year’s IPA Best of Health Awards has been revealed. The IPA’s awards …

News

Wainwright Associates offer more Free Pharmacovigilance and Regulatory Affairs Webinars

May 24, 2011
Business Services Wainwright Associates; free webinars for Pharmacovigilance and Regulatory Affairs

Following the success of the “The roles and responsibilities of an EEA Qualified Person for Pharmacovigilance (QPPV)”  webinar delivered on …

News
Press release

J&J and Vertex’s hep C drug Incivek approved by FDA

May 24, 2011
Sales and Marketing FDA, Incivek, Johnson & Johnson, Vertex, hepatitis C, telaprevir

The FDA has approved Johnson & Johnson/Vertex’s new oral hepatitis C drug Incivek. Incivek (telaprevir), a protease inhibitor, is now …

News

CHMP roundup

May 24, 2011
Sales and Marketing CHMP, EMA, Fampyra, Vibativ, Victrelis, Xgeva, Yervoy

The latest products to be recommended for European approval include MSD’s Victrelis, Astellas Pharma Europe’s Vibativ, Amgen Europe’s Xgeva and …

News

Pfizer and BMS to give Eliquis a rolling launch in Europe

May 24, 2011
Sales and Marketing Eliquis, Pfizer, apixaban, atrial fibrillation

Pfizer and Bristol-Myers Squibb are gearing up to give their new oral anticoagulant Eliquis a rolling launch in Europe, starting …

News
AstraZeneca's Nexium (esomeprazole)

Job cuts at AstraZeneca’s US manufacturing plant

May 24, 2011
Manufacturing and Production AstraZeneca, job cuts

AstraZeneca says it will cut around 135 positions at its manufacturing facility in Westborough, Massachusetts, from the end of this …

News
Sanner's CR-FlipTop caps

Interpack 2011: new product showcase

May 24, 2011
Manufacturing and Production Interpack, manufacturing and production

This year’s Interpack exhibition in Duesseldorf featured the usual crop of new product launches from processing and packaging equipment suppliers. …

News

Uptake of pharma chemicals by crops “an environmental concern”

May 24, 2011
Manufacturing and Production manufacturing and production, pharma manufacturing

Chemicals which enter the environment in the wastewater of pharmaceutical production facilities can be taken up by crops and other …

News
Eli Lilly headquarters

Lilly cuts jobs in Ireland

May 23, 2011
Manufacturing and Production Ireland, job cuts, lilly, manufacturing and production

Eli Lilly has said it is downsizing its plant in County Cork, Ireland, by around 14% in light of patent …

News
The Gateway to Local Adoption Series

Latest content

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026